# A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza

> **NCT02603952** · PHASE1,PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 126 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Oseltamivir
- **DRUG:** MEDI8852
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02603952
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-07
- **Primary completion:** 2016-12-09
- **Final completion:** 2016-12-09
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2018-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02603952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02603952, "A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02603952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*